Winter Charles M. 4
4 · Janux Therapeutics, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Winter Charles M.
Chief Technical Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 totalExercise: $14.02Exp: 2033-01-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on January 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period.